logo
  

Target Announces Return Of Bullseye's Top Toys List This Holiday Season - Quick Facts

Target Corp. (TGT) announced Monday the return of Bullseye's Top Toys list this holiday season, along with plans to expand to over 160 Disney store at Target locations across the country. Target is positioned to inspire children of all ages all season long with more exclusives and only-at-Target experiences in stores and online.

This year's Bullseye's Top Toys list includes 50 Top Toys, with 22 toys and games found only at Target, starting at $19.99.

Gift givers will find top brands like LEGO and L.O.L. Surprise! alongside a range of new additions that will spark creativity. This includes Target's guest-favorite, exclusive 70-piece toy collection with FAO Schwarz, of which 85 percent of items are new this year, popular characters like PAW Patrol and Barbie, and the Zoe Doll by Black-owned business Healthy Roots.

Target's complete toy selection, and nearly all holiday gifts, are available for same-day pickup or delivery through Target's industry-leading fulfillment services; Drive Up, Order Pickup and Same-Day Delivery with Shipt - no membership required. Target RedCard holders can also enjoy five percent off their Top Toys purchases all season long.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim's Cyltezo as the first interchangeable biosimilar to AbbVie's top-selling drug Humira or adalimumab. Cyltezo, originally approved in August 2017, is both biosimilar to, and interchangeable with Humira for Cyltezo's approved uses. The Food and Drug Administration may be planning to allow people to receive Covid-19 vaccine booster shot that is different from the initial dose, reports indicate. The agency is likely to make the announcement on mix and match approach on coronavirus booster vaccines on Wednesday. The move will be part of FDA's expected authorization of boosters for the Moderna and Johnson & Johnson vaccines. Drug major Johnson & Johnson on Tuesday raised again its forecast for fiscal 2021 earnings and sales, which are above market view, after reporting higher results in the third quarter. The company's quarterly adjusted earnings also beat market estimates. In pre-market activity on the NYSE, JNJ shares were gaining around 1.24 percent to trade at $162.10.
Follow RTT